In fact, the level of VEGF expression in resident astrocytes and neurons appears increased in progressive MS patients [35,58], as well as in RR-MS [35], and a reduced level of VEGF has been detected only in non-resident mononuclear cells in CSF and peripheral blood [53,63]. This evidence concerns the gene VEGFA and myeloid sarcoma.